Supportive clinic for people living with advanced or metastatic cancer
Official title: Survivorship Intervention for Patients Living With Advanced and Metastatic Cancers: a Randomized Controlled Feasibility Study
Run by The University of Hong Kong · NCT06465511 · Data updated 2026-11-12
This feasibility study tests whether a community-based survivorship care program can help people with advanced cancer feel better and manage symptoms, in preparation for a future randomized trial.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 5 sites (Hong Kong and 4 other locations) |
| Status | Recruiting |
| Started | May 21, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 31, 2026 |
| Trial ID | NCT06465511 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with advanced or metastatic cancer who can attend the supportive clinic and speak Cantonese, Mandarin, or English in Hong Kong.
✕Probably not a fit
Participants unlikely to benefit include those unable to attend the clinic due to language, mobility, or geographic constraints, or those with conditions not addressed by survivorship care.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project is a feasibility study to determine if a randomized controlled trial of a survivorship care intervention is practical and acceptable for patients with advanced or metastatic cancer. It examines whether a community-based supportive clinic can reduce symptom distress, improve health-related quality of life, and boost self-management self-efficacy. The design compares the supportive clinic to a self-management control, focusing on feasibility outcomes rather than formal efficacy hypotheses. The study follows CONSORT guidelines for feasibility trials and aims to inform a larger definitive trial in the future. Eligible participants are adults with advanced/metastatic cancer who can attend the clinic and speak Cantonese, Mandarin, or English, recruited at Hong Kong-based centers.
Why it matters
Potential benefit: If successful, participants could experience reduced symptom distress and better quality of life through enhanced self-management.
How similar studies have gone: Previous feasibility work in survivorship care has informed activity in diverse cancer settings, but this exact community-based approach for advanced/metastatic cancer remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with advanced or metastatic cancer * are at least 18 years of age * physically able to attend the supportive clinic. Exclusion Criteria: * Participants will be excluded from the study if they are non-Cantonese-, non-Mandarin-, or non-English-speakers.
Where it's running
-
Jcicc
Hong Kong, Hong Kong Recruiting -
Queen Mary Hospital-Department of Obstetrics & Gynaecology
Hong Kong, Hong Kong Recruiting -
Queen Mary Hospital-Department of Oncology
Hong Kong, Hong Kong Recruiting -
Queen Mary Hospital-Department of Surgery
Hong Kong, Hong Kong Recruiting -
Center of Cancer Medicine, Queen Mary Hospital
Hong Kong, Hong Kong Not yet recruiting
Study contacts
- Principal investigator: Wendy Lam, Phd — School of Public Health, The University of Hong Kong
- Study coordinator: Wendy Lam, Phd
- Email: wwtlam@hku.hk
- Phone: +852 39179878
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted prehabilitation to help oral cancer patients return to work
This trial will test an AI-assisted prehabilitation program to help adults with oral cancer reduce physical and emotional problems and return to work.
-
A self-management program for Chinese cancer survivors
This study is testing a self-management program to help Chinese cancer survivors feel better, manage their weight, and improve their overall quality of life after finishing treatment.
-
Histotripsy treatment for pancreatic cancer
This study tests histotripsy, a non-thermal ultrasound method, to see if it can safely target and liquefy pancreatic tumors in adults with unresectable disease.
-
Personalized 3D-printed liver models to pick adjuvant therapy after liver cancer surgery
Doctors test whether a patient’s own 3D-bioprinted liver model can help choose the best additional treatment to lower the chance of cancer coming back after liver surgery.
-
Need-based cancer survivorship program implementation
This project tests a need-based survivorship program for adults who have finished cancer treatment to see if targeted screenings and referrals can help manage symptoms and weight concerns.
-
Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking
This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.